Research Article

Effects of Trimetazidine Pretreatment on Endothelial Dysfunction and Myocardial Injury in Unstable Angina Patients Undergoing Percutaneous Coronary Intervention

Table 3

Serum levels of CK-MB, cTnI, h-FABP, NO, and vWF in the trimetazidine groups, expressed as  ± s.

CK-MB (U/L)cTnI (ng/mL)h-FABP (ng/mL)NO (μmol/L)vWF (ng/ml)

Pre-PCI13.45 ± 3.060.16 ± 0.371.09 ± 0.9760.53 ± 6.872.43 ± 0.58
Post-PCI13.68 ± 8.870.22 ± 0.141.13 ± 1.2160.46 ± 9.192.62 ± 0.54
values0.1130.0510.2840.9050.143

PCI: percutaneous coronary intervention, CK-MB: creatine kinase-muscle/brain, cTnI: cardiac troponin I, h-FABP: heart-type fatty acid-binding protein, vWF: von Willebrand factor, and NO: nitric oxide.